Drug Development and Discovery
Employing innovative solutions to accelerate drug discovery and development
We are committed to advancing drug development and discovery through innovative solutions and unparalleled expertise.
Zenovel is dedicated to enhancing drug development and discovery by offering advanced solutions, addressing challenges, and bringing therapeutic ideas to fruition.
- Overview
Drug research and discovery is an intricate field that involves knowledge, creativity, and accuracy. From original research to clinical development, Zenovel offers comprehensive services for every stage of the drug development process. Our comprehensive strategy guarantees that your medication/ drug candidates satisfy the highest requirements for efficacy, safety, and quality, and are optimised for success. We provide advanced drug development and discovery services, utilizing advanced technologies and a team of experienced scientists, to expedite the development of drug candidates, providing insights and support for innovative therapies.
- Our Key Services include
Zenovel’s Chemistry Services provide comprehensive support in medicinal and synthetic
chemistry, enabling the development of innovative therapeutics from concept to clinic, leveraging the expertise and resources required for drug discovery and development.
Chemistry Services
- Computational Chemistry
- Medicinal Chemistry
- Synthetic Chemistry ( FTE/ FFS Model)
- Custom Synthesis ( Impurities / Metabolites)
- Process Development and CMC
- API Development Strategy
- GMP Manufacturing of NCE/ API
Biology Services
- In-vitro ADME
- In-vitro Biology
- In-vitro Toxicology
- In-vivo Efficacy
- Repeat Dose Toxicology
- In-vivo DMPK
Formulation & Analytical Services
- Pre-formulation Studies
- Dev. of solid, liquid, injectable, & other dosage forms
- Stability Studies as per ICH Guidelines
- Analytical Method Development and Validation
- GMP Manufacturing of Drug Product
- Why Choose Zenovel ?
- Professional Expert Team
Our team, comprising experts in chemistry, biology, pharmacology, and regulatory affairs, offers comprehensive support for drug development projects.
- Advanced Technology
We utilize the latest technologies and methodologies to enhance innovation and efficiency in drug discovery and development.
- Mutual and Combined Approach
Works closely with clients to create conducive environment that enhances project success and expedites development timelines.
- Adherence to Quality
We guarantee the highest quality and regulatory compliance, ensuring your products meet all safety and efficacy guidelines.
- Flexible and Customized Solutions
We offer tailored services to meet the unique needs of your projects, ensuring that your drug candidates are optimized for success.
People Also Ask (FAQs)
Drug development and discovery services involve identifying potential drug candidates, conducting laboratory research, and advancing promising compounds through development stages. These services include biology research, medicinal chemistry, formulation development, and analytical testing to support pharmaceutical innovation.
Drug discovery services help pharmaceutical companies identify new therapeutic compounds and evaluate their biological activity. These services accelerate research and provide the scientific data needed to move promising drug candidates into development and clinical testing.
Drug development includes target identification, compound screening, medicinal chemistry optimization, biological testing, formulation development, and analytical studies. Each stage generates critical data for progress and submissions. Zenovel supports these stages by ensuring structured processes, data integrity, and regulatory alignment throughout development.
Many companies choose drug discovery outsourcing services to access specialized expertise, advanced laboratory capabilities, and experienced scientific teams. Outsourcing also helps reduce research costs and accelerate development timelines.
Zenovel offers integrated drug development and discovery services, including biology research, chemistry services, formulation development, and analytical testing. Their team supports pharmaceutical companies throughout the research and development process to accelerate innovation and ensure high-quality scientific outcomes.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
